Display Settings:

Format

Send to:

Choose Destination
Expert Rev Anti Infect Ther. 2010 Sep;8(9):987-96. doi: 10.1586/eri.10.92.

Emergence and clinical insights into the pathology of Chikungunya virus infection.

Author information

  • 1Groupe de Recherche Immunopathologie et Maladies Infectieuses, Université de la Réunion et CHR Félix Guyon, Plateau technique du CYROI, 2 rue Maxime Rivière, 97470 Sainte-Clotilde, Reunion, France.

Abstract

Major epidemics of Chikungunya have re-emerged with millions of cases worldwide. What was once largely a tropical disease in poorer countries is now recognized as a major global health issue. The disease is perpetuated by the alphavirus Chikungunya, and is transmitted by Aedes mosquitoes. The infection is highly symptomatic, with fever, skin rash and incapacitating arthralgia, which can evolve to chronic arthritis and rheumatism in elderly patients. Mother-to-child transmission, encephalitis, Guillain-Barré syndrome and deaths have been noted. In this article, we will highlight the epidemiological, clinical, virological and immunological aspects of the disease and mention the therapies that have been used during recent epidemics. Novel prevention measures to control the mosquito and a new vaccine are highly warranted.

PMID:
20818943
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk